Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ioniplex is a proprietary, patented fulvic ionic mineral complex derived from ancient humic deposits, developed and manufactured by Mineral BioSciences. It contains a concentrated blend of over 65 trace minerals and fulvic acid, designed to enhance bioavailability and cellular uptake. The primary mechanism of action for Ioniplex is its potent anti-glycation activity, where it inhibits the formation of advanced glycation end products (AGEs) that contribute to cellular aging and metabolic dysfunction. Additionally, it acts as a powerful antioxidant, neutralizing reactive oxygen species (ROS) and protecting mitochondrial integrity. Ioniplex is primarily used as a functional ingredient in dietary supplements to support healthy blood glucose levels, improve mitochondrial energy production, and promote the health of skin, hair, and nails.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ioniplex.